Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

Kidney and heart prevention program after preeclampsia

Official title: Pilotprojekt Renale Und kardiovaskuläre Tertiärprävention Nach Präeklampsie

Run by University Hospital Schleswig-Holstein · NCT07151339 · Data updated 2026-11-12

This program will see if follow-up care plus a biobank can help identify and manage long-term kidney and heart risks for women who had preeclampsia, HELLP, eclampsia, or pregnancy-related kidney disease.

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment100 (estimated)
SponsorUniversity Hospital Schleswig-Holstein
Academic / other
Locations1 site (Kiel)
StatusRecruiting
StartedNovember 1, 2024
Main results expectedNovember 2029
Study endsNovember 2030
Registry record updatedSeptember 3, 2025
Trial IDNCT07151339 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adult women (over 18) with a diagnosis of preeclampsia, HELLP syndrome, eclampsia, or pregnancy-related kidney disease are the intended participants.

Probably not a fit

Those unable to provide informed consent and people without pregnancy-related hypertensive or kidney conditions are unlikely to receive direct benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational program enrolls adult women diagnosed with preeclampsia, HELLP syndrome, eclampsia, or pregnancy-associated kidney disease and follows them after pregnancy. Participants receive guideline-based clinical follow-up while investigators collect medical data and biological samples to create a biobank. No experimental treatments are provided and care follows national and international recommendations. The collected data and samples will be used to better understand long-term renal and cardiovascular risks and to inform future prevention efforts.

Why it matters

Potential benefit: If successful, the program could help identify patients at higher risk of future kidney or heart problems and improve follow-up care and prevention strategies.

How similar studies have gone: Previous cohort and biobank efforts have documented links between preeclampsia and later cardiovascular and renal disease, so this approach builds on existing observational evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* older than 18 yrs
* diagnosed preeclampsia, HELLP syndrome or kidney disease durig pregnancy

Exclusion Criteria:

* unable for informed consent

Where it's running

  • University Hospital Schleswig- Holstein
    Kiel, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.